Acadia Healthcare (NASDAQ:ACHC) Stock Rating Upgraded by Raymond James Financial

Key Points

• Raymond James upgraded Acadia Healthcare to a "strong-buy" with a $39 price target, implying about a 40% upside from the prior close.
• Acadia reported Q1 EPS of $0.37 vs. $0.28 consensus and revenue of $828.8M (up 7.6% YoY), and set Q2 guidance of $0.30–$0.40 EPS.
• The analyst picture is mixed: MarketBeat shows a consensus rating of "Hold" with a $25.12 average price target, though several firms recently raised targets into the ~$30–$31 range and one firm remains a sell.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was upgraded by investment analysts at Raymond James Financial from an "outperform" rating to a "strong-buy" rating in a report issued on Monday. The brokerage presently has a $39.00 price target on the stock. Raymond James Financial's price objective would indicate a potential upside of 40.04% from the stock's previous close.

Several other analysts have also commented on ACHC. TD Cowen increased their price target on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a "buy" rating in a research report on Tuesday, April 28th. Jefferies Financial Group reissued a "hold" rating and set a $24.50 price target on shares of Acadia Healthcare in a research report on Monday, April 20th. UBS Group upped their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a "buy" rating in a report on Friday, April 17th. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Finally, Cantor Fitzgerald upped their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a "neutral" rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of "Hold" and a consensus price target of $25.12.

Acadia Healthcare Stock Performance

ACHC stock opened at $27.85 on Monday. The firm has a market cap of $2.56 billion, a price-to-earnings ratio of -2.28, a PEG ratio of 9.39 and a beta of 0.73. The firm has a 50-day simple moving average of $24.43 and a two-hundred day simple moving average of $19.12. Acadia Healthcare has a one year low of $11.43 and a one year high of $28.57. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company's quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts forecast that Acadia Healthcare will post 1.48 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. increased its holdings in Acadia Healthcare by 112.1% in the 3rd quarter. Principal Financial Group Inc. now owns 442,943 shares of the company's stock worth $10,967,000 after buying an additional 234,107 shares during the period. Invenomic Capital Management LP increased its holdings in Acadia Healthcare by 41.6% in the 3rd quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company's stock worth $47,945,000 after buying an additional 568,796 shares during the period. Vanguard Group Inc. increased its holdings in Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company's stock worth $233,166,000 after buying an additional 681,278 shares during the period. First Citizens Bank & Trust Co. increased its holdings in Acadia Healthcare by 164.1% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company's stock worth $1,464,000 after buying an additional 36,733 shares during the period. Finally, Public Sector Pension Investment Board acquired a new position in Acadia Healthcare in the 3rd quarter worth approximately $8,919,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.